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Introduction: A total of 38 brain cytoarchitectonic subdivisions, representing subcortical and cortical structures,
cerebellum, and brainstem, were examined in 4- to 60-year-old subjects diagnosed with autism and control
subjects (a) to detect a global pattern of developmental abnormalities and (b) to establish whether the function of
developmentally modified structures matches the behavioral alterations that are diagnostic for autism. The volume
of cytoarchitectonic subdivisions, neuronal numerical density, and total number of neurons per region of interest were
determined in 14 subjects with autism and 14 age-matched controls by using unbiased stereological methods.
Results: The study revealed that significant differences between the group of subjects with autism and control groups
are limited to a few brain regions, including the cerebellum and some striatum and amygdala subdivisions. In the
group of individuals with autism, the total number and numerical density of Purkinje cells in the cerebellum were
reduced by 25% and 24%, respectively. In the amygdala, significant reduction of neuronal density was limited to the
lateral nucleus (by 12%). Another sign of the topographic selectivity of developmental alterations in the brain of
individuals with autism was an increase in the volumes of the caudate nucleus and nucleus accumbens by 22% and
34%, respectively, and the reduced numerical density of neurons in the nucleus accumbens and putamen by 15%
and 13%, respectively.
Conclusions: The observed pattern of developmental alterations in the cerebellum, amygdala and striatum is
consistent with the results of magnetic resonance imaging studies and their clinical correlations, and of some
morphometric studies that indicate that detected abnormalities may contribute to the social and communication
deficits, and repetitive and stereotypical behaviors observed in individuals with autism.
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Autism is a lifelong disorder characterized by disrupted
development of social and communication skills and
restricted, repetitive, and stereotypical patterns of behav-
ior, interests, and activities. In nearly 50% of individuals
later diagnosed with autism, functional alterations are
noted at between 14 and 24 months, and alterations are
observed in all three diagnostic functional domains at
24 months of age [1,2].
In the past three decades, numerous studies have been
conducted on the trajectory of brain overgrowth, differ-
ences between the sizes of individual brain structures
and regions, and the abnormal number and size of neu-
rons in the brain in autism spectrum disorder (ASD). A
large cluster of studies has focused on distortion of the
trajectory of brain growth, which may involve modifica-
tions of the brain and of brain structure volumes as well
as of the number of neurons. A rapid increase in head
circumference at 1–2 years of age [3-7] followed by a
slower rate of brain growth between 2 and 4 years of age
[8-11] reportedly results in only a 2% larger brain size in
adult patients with autism [12] or a smaller brain size
[13] in comparison to control subjects. However, recent
analysis by Raznahan et al. [14] revealed that the vast
majority (83%) of head circumference studies in ASD
used head circumference norms as comparison data.
Reassessment of evidence of early brain overgrowth
revealed that studies using head circumference norms
are significantly more likely to identify head circumference
abnormalities in ASD than are comparisons between head
circumference data of children with ASD and locally re-
cruited control subjects [14]. The authors of this analysis
suggest that reports of early brain overgrowth in children
with ASD reflect replicable Centers for Disease Control
and Prevention norm biases rather than a disease-related
phenomenon. However, there is no doubt that in several
genetic syndromes characterized by autistic-like beha-
vior, the brain is enlarged [15], or affected individuals are
microcephalic [16,17].
Individual brain structures have distinct developmental
profiles from the trajectory of brain development [18-20].
Growth abnormalities of various brain regions involved in
cognitive, social, and emotional functions and language
development are considered to be a reflection of their con-
tribution to the clinical autism phenotype [9-11,21]. Some
postmortem studies suggest that volumetric changes are
associated with an increase or decrease in the number of
neurons. Courchesne et al. [22] revealed 67% more neu-
rons in the prefrontal cortex in 2- to 16-year-old individ-
uals with autism and linked these differences to prenatal
disturbances of mechanisms that govern proliferation,
cell cycle regulation, and apoptosis. Santos et al. [23]
demonstrated insignificantly more von Economo neu-
rons in the frontoinsular cortex in 4- to 11-year-oldchildren diagnosed with autism than in controls (p = 0.054),
but the contribution of this small population of neurons to
the volume of this cortical region is marginal. However,
the majority of reports show that the numbers of many
neuronal populations in the brain structures of individ-
uals with autism are unmodified [23-28] or regionally
decreased [29-34].
This project was designed to partially reduce the limi-
tations of research outcome due to the small size of the
cohort examined with (a) different methods of tissue
preservation and evaluation and (b) concentration of the
study on a few brain regions. Four parameters—brain
weight, the volume of brain structures’ cytoarchitectonic
subdivisions, the total number of neurons, and the nu-
merical density of neurons per region of interest—were
selected to detect developmental and age-associated al-
terations in the brains of 14 individuals diagnosed with
autism and 14 control subjects. The aim of the study of
14 brain structures and their 24 subdivisions (layers, sec-
tors, nuclei) including subcortical and cortical structures,
cerebellum, and brainstem was to identify a global pattern
of alterations and to establish whether the function of
altered structures matches the behavioral alterations that
are diagnostic for autism.
Materials and methods
Originally, 39 brains were assigned to this study of de-
velopmental abnormalities in autism, including 21 brains
of subjects diagnosed with autism and 18 control brains.
Application of clinical inclusion criteria and neuropatho-
logical exclusion criteria reduced the size of this cohort
to 28 subjects, comprising 14 subjects with autism and
14 age-matched control individuals. Two cases did not
meet the Autism Diagnostic Interview-Revised (ADI-R)
[1] criteria for diagnosis of autism. One affected subject
and four control subjects were excluded because of severe
brain autolysis, and the brains of three subjects with
autism were excluded because of hypoxic encephalopathy,
and another one because of multiple microinfarcts [35].
The clinical diagnosis of autism was confirmed by a
postmortem application of the ADI-R. Results of the
ADI-R and the clinical characteristics of this cohort have
been summarized by Wegiel et al. [35]. Eight subjects
with autism (57%) were affected by mild to severe intel-
lectual deficits, which were detected using the Wechsler
Intelligence Scale for Children III and the Woodcock-
Johnson Tests of Achievement-Revised. Seven of the 14
subjects with autism were diagnosed with seizures (50%),
and in five cases (36%), death was seizure-related.
Neuropathological evaluation revealed various types of
developmental abnormalities in 13/14 brains of individuals
diagnosed with autism (93%), which were summarized in
our previous report [36], including (a) defects of prolife-
ration with subependymal nodular dysplasia, (b) defects of
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heterotopias, and (c) dysplastic changes in the neo-
cortex, archicortex, dentate gyrus, Ammons horn, and
cerebellum.
The study has been approved by the institutional review
board (Application # 463) of the New York State Institute
for Basic Research in Developmental Disabilities.
Tissue processing, embedding, sectioning, and staining
Tissue samples, demographics of individuals with autism
and control subjects, brain weight, and changes during
processing were characterized in our previous report [35].
In short, the postmortem interval (PMI), corresponding to
the period between death and autopsy, ranged from 6 to
28 hours in the control group, and from 3 to 50 hours in
the affected group, but the difference in PMI between the
two groups was not significant. The average weight of the
brains in the cohort with autism (1,453 g) was not signifi-
cantly different from that in the control group (1,372 g).
The brain hemisphere was fixed with 10% buffered for-
malin for an average of 408 days in the control group and
905 days in the affected group. Brain dehydration in a
series of ascending concentrations of ethyl alcohol for 36
and 38 days in the control and affected groups, respect-
ively, resulted in reduction of brain hemisphere weight
by 47% on average in the group of subjects diagnosed
with autism and by 45% in the control group. Brain
hemispheres were embedded in 8% celloidin [37]. Serial
200-μm-thick sections stained with cresyl violet and
mounted with Acrytol were used for morphometric
studies.
Delineation of regions of interest
The anatomical boundaries of the examined brain
structures and their cytoarchitectonic subdivisions were
described in detail in our previous report [35]. Delineation
of structures requiring micrographs is illustrated with
Figures 1 and 2, which show partitioning of the striatum
(caudate nucleus, putamen, nucleus accumbens and glo-
bus pallidus); the amygdala (lateral, basal, accessory basal
and central nuclei); layers of the entorhinal cortex; and
sectors in the Ammons horn.
The rostral striatum is divided into the caudate nu-
cleus and the putamen by the internal capsule. The
border between the nucleus accumbens, the caudate
nucleus and the putamen was arbitrarily defined by a
line perpendicular to the midline of the internal capsule
at its ventral end [38]. The number of striatal small neu-
rons was estimated but a few dispersed large neurons
[39] were not included in this study. The external me-
dullary lamina marks the border between the putamen
and the globus pallidus. The medial medullary lamina
divides the globus pallidus into the external and internal
pallidum [40]. The number of neurons was determinedin both parts of the pallidum. The boundaries of the
lateral, basal, accessory basal and central nuclei were
delinated using cytoarchitectonic criteria described in
detail by Schumann and Amaral [31,41]. The entorhinal
cortex (EC, Brodmann area 28) occupies the gyrus ambiens
and the anterior portion of the hippocampal gyrus. The
anterior border of the EC starts a few millimeters rostrally
to the amygdala complex. The EC ends rostrally to the lat-
eral geniculate body. The medial portion of the EC borders
with the preamygdaloid cortex and caudally with the
subicular complex. The lateral portion of the EC borders
with Brodmann area 35, which lacks a distinct layer IV
[42]. The transentorhinal zone [43] was not included in
this study. Neurons were measured within four layers of
the EC. Layer II consists of islands of large modified pyr-
amidal and stellate neurons separated by an acellular gap
from layer III. A broad layer III is built up of medium-
sized pyramidal neurons separated from layer V by the
lamina dissecans, labeled as layer IV. Layer V consists of
the large pyramidal neurons, whereas Layer VI is built up
of the smallest neurons with a decreasing gradient of neur-
onal density in the deep portion of this layer [42].
In Ammon’s horn the number of neurons was estimated
in the pyramidal layer in sectors CA1–4. The CA1 sector
pyramidal neuronal layer extends from the subiculum to
the CA2 sector as a thick band of medium size pyramidal
neurons. Two features distinguish the CA2 sector: a com-
pact arrangement of large pyramidal neurons and the low-
est thickness of this layer. The size of neurons in the CA3
and 4 is similar, but parallel arrangement of neurons
in the CA3 sector distinguishes CA3 from randomly
dispersed neurons in the hilus, identified also as CA4
sector [42,44]. The mapping of sectors on serial sections
was based on the Amaral and Insausti [42] classifica-
tion, but the CA4 sector has been delinated as a separate
subdivision.
The neurons were distinguished from glial cells by
using histological features revealed by cresyl violet stain-
ing, including neuron size, shape, and spatial orientation
typical for specific layers, sectors, and brain nuclei, as
well as the pattern of staining of nuclear chromatin, the
distinct nucleolus in the majority of examined neuronal
populations, and cytoplasm morphology. Small and
round nuclei with uniform, intense staining of nuclear
chromatin distinguished oligodendrocytes from astrocytes
with large, round nuclei with a small amount of dispersed
chromatin and an undetectable nucleolus.
Stereological analysis
Volume evaluation and counting of neurons were per-
formed using a workstation consisting of an Axiophot II
(Carl Zeiss, Goettingen, Germany) light microscope with
Plan-NEOFLUAR objectives—1.25 × (numerical aperture, N.
A., 0.035), 2.5 × (N.A. 0.075), 5 × (N.A. 0.15), 20 × (N.A. 0.5),
Figure 1 Delineation of the striatum subdivisions, the amygdala nuclei and anterior portion of the entorhinal cortex. Panel A shows
three serial coronal sections (271, 313, and 334) stained with cresyl violet. Rectangles mark inserts that are shown enlarged in panel B. Section
271 shows delineation of the caudate nucleus (CN), putamen (Pu) and nucleus accumbens (Ac). Enlargements of sections 313 and 334
demonstrate the borders of the lateral (L), basal (B), accessory basal (AB), and central (C) nuclei within the amygdaloid complex. The adjacent
median (M) nucleus, preamygdaloid cortex (PAC), and ventral claustrum (VCl) are marked. The borders of the enorhinal cortex (EC) are delinated
including the borderline with the transentorhinal cortex (TEC) and PAC. Higher magnification (Panel C) shows EC layers typical for the mid-level
of the rostrocaudal EC extension including layer I (molecular layer); islands of stellate neurons in layer II; a broad layer III; and acellular layer IV. On
this level large darkly stained neurons form narrow layer (V), whereas the broad layer VI is built up of the smallest neurons, with decreasing gradient of
neuronal density in the deeper part of this layer and a diffuse border with white matter (WM). Other examined structures: globus pallidus (GP),
claustrum (Cl), and thalamus (Th). Calibration bar length: 10 mm, 5 mm, and 500 μm.
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Figure 2 Delination of the Ammons horn sectors and the posterior portion of the entorhinal cortex. Panel A shows CV-stained hemispheric
sections on the level of the hippocampal head (s. 376), body (s. 412) and tail (s. 490). The rectangle in panel A marks an area that was enlarged 5-fold
and is shown in panel B. Stereologically examined structures are labeled as: sectors CA1, 2, 3, 4; EC, entorhinal cortex; CN, caudate nucleus; Pu,
putamen; GP, globus pallidus; Cl, claustrum; Th, thalamus; and SN, substantia nigra. The subicular complex is labeled as Sub C. Calibration bar length:
10 mm and 5 mm.
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computer-controlled stepping motor system (Ludl Elec-
tronics; Hawthorne, NY, USA); a CCD color video camera
(CX9000, MicroBrightfield Bioscience, Inc., Williston, VT,USA); and stereology software (Stereo Investigator, Micro-
Brightfield Bioscience).
The parameters and procedures that were applied to
estimate the volume of brain regions and the number of
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their subdivisions were delineated at a low magnification
of 1.25 × (47 × final mag.), 2.5 × (95x), or 5 × (190x) to de-
termine the volume of the region of interest. The number
of neurons was estimated by using a 40x lens (final mag-
nification, 1,450x), and the number of Purkinje cells, by
using a 20x lens (final magnification, 720x). The numerical
density of Purkinje cells (n/mm3) was estimated in the
cerebellar cortex, including molecular and granule cell
layers. An optical fractionator systemic random sampling
scheme was applied (Stereo Investigator, MicroBright-
field). Twelve equidistant serial sections were used for
neuronal counts in the anatomical subdivisions of the
amygdala; 10 in the substantia nigra; 14 in cornu Ammo-
nis sectors CA1–CA4; 13 in the claustrum; 16 in the mag-
nocellular basal complex; 6 in the thalamus, entorhinal
cortex, globus pallidus, and nucleus accumbens; 9 in the
caudate nucleus and putamen; 8 in the cerebellum and in













Amygdala (four nuclei) 12 1.25x 40x 1000
Thalamus 6 1.25x 40x 1000
Entorhinal c.
LII 6 2.5x 40x 400
LIII 6 2.5x 40x 800
LV 6 2.5x 40x 600
LVI 6 2.5x 40x 800
CA1 14 2.5x 40x 1000
CA2 14 2.5x 40x 400
CA3 14 2.5x 40x 400
CA4 14 2.5x 40x 600
Caudate nucleus 9 2.5x 40x 1400
Putamen 9 2.5x 40x 1400
Globus pallidus 6 2.5x 40x 300
Nucleus accumbens 6 2.5x 40x 700
Magnocellular LGB 4 5x 40x 500
Parvocellular LGB 4 5x 40x 500
Claustrum 13 1.25x 40x 250
Substantia nigra 10 2.5x 40x 500
Magnocellular basal complex
(Ch1-Ch4)
16 2.5x 40x 500
Dentate nucleus 11 2.5x 40x 1000
Inferior olive 8 2.5x 40x 1000
Cerebellum 8 1.25x 20x 1800
Number of sections examined = mean number of equidistant sections examined pe
Obj. (Vol.) = Objective lens (1.25x, 2.5x, or 5x) used to provide final magnification fo
Obj. (Numb.) = Objective lens (40x or 20x) used for fractionator to estimate neuron
*CE = the average predicted Coefficient of Error of the neuronal counts (Scheaffer).related to sectioning defects was reduced by application of
5-μm-wide top and bottom guard zones. The results of
examination of the cytoarchitectonic subdivisions are
presented as the mean number of neurons per mm3
(neuronal density) and the total number of neurons
per region of interest. The sizes of the grid and of the
virtual counting space were adjusted to the size and shape
of the examined regions. The number of virtual counting
spaces ranged from 62 per subdivision per case in a very
small subdivision such as the fifth layer in the ento-
rhinal cortex (coefficient of error; CE, 0.003) to 1953
in the globus pallidus with a low neuronal numerical
density (CE, 0.04).
The mean volumes, number of neurons, and neuronal
density of structures in autistic and control brains were
compared in analyses of covariance (ANCOVAs) and
repeated measures analysis of variance in which brain
weight and, for neuronal counts and density, log age,














× 1000 80 × 80 × 10 356 454 0.01
× 1000 80 × 80 × 10 188 313 0.01
× 400 60 × 60 × 30 113 164 0.003
× 800 60 × 60 × 30 118 277
× 600 60 × 60 × 30 62 161
× 800 60 × 60 × 30 68 184
× 1000 60 × 60 × 30 207 543 0.003
× 400 60 × 60 × 30 121 337
× 400 60 × 60 × 30 144 330
× 600 100 × 100 × 30 130 429
× 1400 60 × 60 × 30 270 751 0.04
× 1400 60 × 60 × 30 309 844
× 300 80 × 80 × 30 1953 505
× 700 60 × 60 × 30 202 749
× 500 100 × 100 × 30 96 230 0.002
× 500 100 × 100 × 30 134 1,418 0.002
× 250 60 × 60 × 10 274 318 0.01
× 500 80 × 80 × 30 366 493 0.002
× 500 80 × 80 × 30 323 507 0.005
× 1000 180 × 180 × 30 335 792 0.002
× 1000 180 × 180 × 30 213 364 0.002
× 1800 180 × 180 × 30 1419 773 0.05
r structure/case.
r planimetry and volumetry.
al density and total number of neurons.
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age and the total number and density of neurons in the
autistic and control cohort.
Results
Repeated measures analysis of variance
To test the hypotheses that structures differ in the degree
to which autism affects, first, the number of neurons in
the structure and, second, the volume of the structure, we
conducted repeated measures analyses of variance with
structure and autistic status as factors, with the potential
confounders of brain weight, post-mortem interval, days
of fixation, and log age entered as covariates. The signifi-
cant interaction of structure with autistic status in each
case indicates that autism’s effect upon the number of
neurons (F[df = 13] = 2.138, p < .018) and upon structural
volume (F[df = 13] = 10.278, p < .001) differs among the
structures examined.
Volume of brain subdivisions
In the control group, the volume of 14 brain struc-
tures and their 24 subdivisions ranged from the lar-
gest structures, such as the thalamus, putamen, and
caudate nucleus (2,999 mm3, 2,365 mm3, and 1,727 mm3,
respectively) to the smallest inferior olive (59 mm3)
(Figure 3). Table 2 summarizes the results of estimation
of the volume of brain regions and their cytoarchitectonic
subdivisions as the absolute volume calculated using
mounted section thickness (StereoInvestigator, Micro-
brightfield). To compare the results of volume estimates
with other reports, the volume was corrected for 47%
tissue shrinkage during dehydration for the autism group
and 45% shrinkage for the control group. A significant dif-
ference between the volumes of the examined structures
in the affected and control cases was detected only in the
caudate nucleus and nucleus accumbens. In the group
with autism, caudate nucleus volume was larger by 22%
(2,107 mm3 in the autism cohort, and 1,727 mm3 in the
control cohort; p < 0.036). The nucleus accumbens was
larger by 34% (244 mm3 in the autism cohort, and
182 mm3 in the control cohort; p < 0.050). However, ana-
lysis of alterations in 4- to 8-year-old children did not
reveal a significant difference between the affected and
control groups. The finding of a significantly larger caud-
ate nucleus and nucleus accumbens only in 9- to 60-year-
old individuals with autism suggests that the difference
may be a result of changes during adolescence/adulthood.
The mean volume of the examined cerebellar hemi-
sphere was almost identical in the affected and control
groups: 31,779 mm3 and 31,133 mm3, respectively. The
mean volume of the molecular and granule cell layers
(12,623 mm3 and 12,092 mm3, respectively), and the
percentage of the cerebellar cortex occupied by these
two layers (51% and 49%, respectively) in the group withautism did not reveal a significant difference in compari-
son to the control group (12,885 mm3 and 11,926 mm3,
respectively; with the volume ratio 52% and 48%, respect-
ively). The mean volume of white matter was almost the
same in the affected and control cohorts (6,700 mm3 and
6,005 mm3, respectively), as was the percentage of the
cerebellar volume occupied by white matter (21% and
19%, respectively). Also, the volume of cerebellar nuclei
(364 mm3 and 317 mm3, respectively), including the
largest dentate nucleus (244 mm3 and 232 mm3, respect-
ively), did not reveal a significant difference between indi-
viduals with autism and control subjects.
Number of neurons
Application of the fractionator method to determine the
total number of neurons in 15 brain structures and their
16 cytoarchitectonic subdivisions in control subjects
(Table 3) revealed 49 million to 65 million neurons in
the three largest structures, including the thalamus,
caudate nucleus, and putamen, and 7 million to 15 million
in medium-size structures such as the nucleus accumbens,
amygdala, entorhinal cortex, claustrum, and Ammons horn.
In the smallest examined brain structures, the number of
neurons ranged from 0.7 million in the substantia nigra to
1.4 million in the lateral geniculate body. Examination of
31 brain regions and cytoarchitectonic subdivisions re-
vealed a significantly lower total number of neurons only
in the second layer of the entorhinal cortex (813,252 in
subjects with autism and 1,023,270 in control subjects;
p < 0.013 not corrected for log of age, brain weight,
postmortem interval, and days of fixation). In two af-
fected cases, neuronal deficit in the entorhinal cortex
was detected without the support of morphometric
methods, as the paucity of focal stellate neurons in disor-
ganized islands that were smaller than normal. However, a
reduction of the mean total number of neurons to 788,879
and the shift of significance to p < 0.007 after removal of
these two cases from the analysis indicates that these focal
developmental defects contribute less to the decrease of
the mean number of stellate neurons than do diffuse defi-
cits not detectable without morphometric support.
The numerical density of neurons was brain region–
specific and varied in the control group from 2,339/mm3
in the globus pallidus to 40,031/mm3 in the nucleus ac-
cumbens. In the group with autism, a significantly lower
numerical density of neurons was detected in three brain
regions: the lateral nucleus in the amygdala (24,390/
mm3 in the affected group and 27,446/mm3 in the control
group; p < 0.017), putamen (23,749/mm3 in the affected
group and 27,531 mm3 in the control group; p < 0.041),
and nucleus accumbens (33,107/mm3 in the affected group
and 40,031/mm3 in the control group; p < 0.018). Box plots
demonstrate that in the majority of subjects with autism
the numerical density of Purkinje cells, neurons in the
Figure 3 Brain structure volume, total number of neurons and neuronal density. Range of the volume of examined regions from the
largest (thalamus, putamen, and caudate) to the smallest (inferior olive). The volume of all four striatum subdivisions, including putamen, caudate
nucleus, globus pallidus, and nucleus accumbens, is greater in subjects with autism, but the difference in this volume between affected and
control subjects is significant only in the caudate and nucleus accumbens (black stars). The total number of neurons was found to be significantly
less only in the second layer of the entorhinal cortex (white star) when covariates were not entered in the analysis. Although the total number of
neurons does not reveal significant differences, the numerical density is significantly reduced in the nucleus accumbens and putamen of subjects
with autism. The significantly lower numerical density of neurons is observed in the lateral nucleus of the amygdala (white star), but not in other
amygdala nuclei. Cerebellar volume and the volume of the molecular and granule cell layers, cerebellar white matter, and cerebellar nuclei do
not reveal differences between affected and control subjects; however, the total number of Purkinje cells was 25% less (p < 0.03) in the group
with autism (12.1 million) than in the control group (16.0 million). The numerical density of Purkinje cells was also significantly less (p < 0.004) in
the affected group than in the control group (488/mm3 and 645/mm3, respectively). Th, Thalamus; Pu, putamen; CN, caudate nucleus; AH,
Ammons horn; EC, entorhinal cortex; GP, globus pallidus, Cl, claustrum; Am, amygdala; DN, dentate nucleus; Ac, nucleus accumbens; SN, substantia
nigra; MBC, magnocellular basal complex; LGB, lateral geniculate body; IO, inferior olive; Crb, cerebellum; ML, molecular layer; GCL, granule cell layer;
WM, white matter; Nu, cerebellar nuclei.
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in the putamen is less than the median numerical density
in the control group (Figure 4).
The volume of cerebellum and cerebellar subdivisions
as well as the number of neurons was estimated after
exclusion of records for brain samples of two subjects
with autism: one with focal defects of cresyl violet stain-
ing related to poor fixation, and the second because of
focal dysplasia. A 60-year-old subject with autism and
clinically diagnosed disturbed movement coordination
and postmortem-detected severe hypoplasia of cerebellar
lobes I-IV [36] was excluded from statistical analysis to
eliminate the impact of one case of focal developmental
defect on estimates of developmental alterations in anexamined group of subjects with autism. In this cere-
bellum, the numerical density of Purkinje cells was 2.3
times less (274/mm3) in the hypoplastic area than in the
control cerebellar cortex. The total number of Purkinje
cells was 42% less in this case (7.1 million) than the
mean total number in the examined hemisphere of other
subjects with autism and 65% less than in the control
group.
The average total number of Purkinje cells within the
examined cerebellar hemispheres was significantly less
(p < 0.0001) in the group with autism (12.1 million) than
in the control cohort (16. million) (25% deficit). The
minimal number of Purkinje cells in the examined hemi-
sphere in the control group was 11.4 million, but in five
Table 2 Mean volume (±SE) of 14 brain structures and 24 cytoarchitectonic subdivisions in one brain hemisphere of
autistic and control subjects*
Brain structure or cytoarchitectonic
subdivision




Autism Control p < Autism Control
Thalamus 3,030 ± 116 2,999 ± 92 ns 5,717 5,453
Putamen 2,597 ± 165 2,365 ± 111 ns 4,900 4,300
Caudate nucleus 2,107 ± 114 1,727 ± 114 0.036 3,975 3,140
Cornu Ammonis (CA) 598 ± 33 602 ± 30 ns 1,128 1,096
- CA1 439 ± 22 432 ± 23 ns 828 785
- CA2 32 ± 3 36 ± 2 ns 60 65
- CA3 44 ± 3 45 ± 4 ns 83 82
- CA4 84 ± 7 89 ± 6 ns 158 162
Entorhinal cortex (EC) I-VI 589 ± 39 557 ± 36 ns 1,111 1,012
- EC I 71 ± 4 63 ± 4 ns 134 115
- EC II (Islands) 38 ± 3 42 ± 4 ns 72 76
- EC III 254 ± 17 244 ± 16 ns 479 444
- EC IV 23 ± 3 17 ± 5 ns 43 31
- EC V 60 ± 4 62 ± 5 ns 113 113
- EC VI 143 ± 10 129 ± 9 ns 270 234
Globus pallidus 611 ± 36 561 ± 25 ns 1,153 1,020
- External globus pallidus 412 ± 28 364 ± 29 ns 777 662
- Internal globus pallidus 199 ± 10 197 ± 10 ns 375 358
Claustrum 432 ± 32 442 ± 27 ns 815 804
- Insular claustrum 237 ± 19 241 ± 16 ns 447 438
- Prepiriform claustrum 194 ± 14 201 ± 13 ns 366 365
Amygdala 397 ± 43 405 ± 22 ns 749 736
- Basal nucleus 113 ± 15 116 ± 8 ns 213 211
- Lateral nucleus 189 ± 20 202 ± 13 ns 356 367
- Accessory basal nucleus 82 ± 10 76 ± 6 ns 155 138
- Central nucleus 13 ± 1 11 ± 1 ns 25 20
Nucleus accumbens 244 ± 23 182 ± 13 0.050 460 331
Substantia nigra 98 ± 6 88 ± 4 ns 185 160
Magnocellular basal complex 84 ± 8 81 ± 5 ns 158 147
Lateral geniculate body 80 ± 5 77 ± 4 ns 151 140
Inferior olive 62 ± 2 59 ± 4 ns 117 107
Cerebellum 31,779 ± 1,304 31,133 ± 1,397 ns 59,959 56,605
- Cerebellar cortex (calculated) 24,715 24,811 ns 46,632 45,111
- Molecular layer 12,623 ± 443 12,885 ± 758 ns 23,816 23,427
- Granule cell layer 12,092 ± 611 11,926 ± 474 ns 22,815 21,684
- Cerebellar white matter 6,700 ± 380 6,005 ± 323 ns 12,641 10,918
- Cerebellar nuclei 364 ± 34 317 ± 21 ns 686 576
- Dentate nucleus 244 ± 14 232 ± 13 ns 511 422
*Statistical significance controlled for brain weight and brain weight decrease during dehydration (%) entered as covariate. ns = not significant.
Volume (mm3) corrected for shrinkage: autism, 47%; control, 45%.
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Table 3 Total number of neurons per region and neuronal numerical density in 15 structures and 16 cytoarchitectonic
subdivisions in examined brain hemisphere of individuals with autism and control subjects*
Structure/cytoarchitectonic
subdivision
Total number of neurons per region Neuronal numerical density (N/mm3)
Autism Control p < Autism Control p <
Putamen 61,675,039 65,111,021 ns 23,749 27,531 0.041
Caudate nucleus 54,693,459 49,292,390 ns 25,958 28,542 ns
Thalamus 47,403,083 49,291,830 ns 15,645 16,436 ns
Cornu Ammonis (CA) 14,812,043 15,047,614 ns 24,769 24,955 ns
- CA1 11,575,341 11,533,806 ns 26,368 26,699 ns
- CA2 1,051,901 1,152,120 ns 32,872 32,003 ns
- CA3 1,054,780 1,124,862 ns 23,972 24,997 ns
- CA4 1,130,021 1,236,826 ns 13,453 13,897 ns
Claustrum 12,351,088 12,917,584 ns 28,590 29,225 ns
- Insular claustrum 6,576,940 6,729,652 ns 27,751 27,924 ns
- Prepiriform claustrum 5,774,148 6,187,932 ns 29,764 30,786 ns
Entorhinal cortex (EC) 11,878,538 12,915,740 ns 23,997 27,077 ns
- EC Islands 813,252 1,023,270 ns† (0.013) 21,401 24,364 ns
- EC III 5,553,881 6,071,044 ns 21,866 24,881 0.021
- EC V 1,871,129 2,008,421 ns 31,185 32,394 ns
- EC VI 3,640,276 3,813,005 ns 25,456 29,558 ns
Amygdala 9,819,741 11,138,599 ns 24,735 27,503 ns
- Basal nucleus 2,821,429 3,154,350 ns 24,968 27,193 ns
- Lateral nucleus 4,609,751 5,544,098 ns 24,390 27,446 0.017
- Accesory basal nucleus 2,046,439 2,109,385 ns 24,957 27,755 ns
- Central nucleus 342,122 330,766 ns 26,317 30,070 ns
Nucleus accumbens 8,078,093 7,285,654 ns 33,107 40,031 0.018
Lateral geniculate body 1,493,426 1,392,966 ns 18,668 18,090 ns
Globus pallidus 1,277,936 1,312,262 ns 2,092 2,339 ns
- External globus pallidus 899,307 904,365 ns 2,183 2,485 ns
- Internal globus pallidus 378,629 407,897 ns 1,903 2,071 ns
Dentate nucleus 970,440 918,809 ns 3,977 3,960 ns
Magnocellular basal complex 768,415 790,893 ns 9,148 9,764 ns
Inferior olive 793,002 716,895 ns 12,790 12,151 ns
Substantia nigra 744,247 707,228 ns 7,594 8,037 ns
Cerebellum (Purkinje cells) 12,060,920 16,003,095 0.0001 488 645 0.0024
*Controlled for log age, brain weight, post-mortem interval, days of fixation, and percentage of brain weight loss during dehydration entered as covariates.
†The total number of neuronal deficit (by 20%; p < 0.013) in stellate neuron islands in the entorhinal cortex was not significant only when log age, brain weight,
post-mortem interval, and days of fixation were entered as covariates.
Wegiel et al. Acta Neuropathologica Communications 2014, 2:141 Page 10 of 18
http://www.actaneurocomms.org/content/2/1/141of 12 examined subjects in the affected group (42%), the
number was less than in this control subject. The total
number of Purkinje cells was less in all individuals with
autism than the average number in the control group.
The numerical density of Purkinje cells was also signifi-
cantly less (p < 0.0024) in affected subjects (488/mm3)
than in control subjects (645/mm3) (−24.4%).
The absence of a significant correlation between age
and the total number or numerical density of neurons
(N/mm3) in the cohort with autism suggests that thedetected neuronal deficits do not decrease greatly, if at
all, from 4 to 60 years of age among subjects diagnosed
with autism. However, examination of only three subjects
with autism 52 to 60 years of age and of three control sub-
jects 51–64 years of age is not favorable for detection of
aging-associated neuronal loss.
Discussion
Estimates of the volume of 38 brain subdivisions, neuronal
number per cubic millimeter, and neuronal number per
Figure 4 Numerical density of Purkinje cells, and neurons in the lateral nucleus in the amygdala, nucleus accumbens and in the
putamen. Box plots demonstrate the considerable differences between the median numerical density (thick line within the box) of Purkinje cells
(n/mm3), and between the number of neurons in the lateral nucleus in the amygdala, nucleus accumbens and putamen (thousands/mm3) in the
group with autism and control groups. In the majority of individuals diagnosed with autism, the numerical density of neurons is less than the
median numerical density in the control group. The upper and lower boundaries of each box represent the 75th and 25th percentiles of the
data, respectively; the depth of the box thus represents the interquartile range (IQR). The “whisker” above the box is the maximum value unless
any data point lies more than 1.5 times the IQR above the 75th percentile, in which case the maximum value is the 75th percentile plus 1.5 times
the IQR, and the points outside it (outliers) are indicated by circles. The lower whisker and outliers are computed analogously.
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cant alterations in the group of subjects with autism are
limited to the caudate nucleus and nucleus accumbens in
the striatum, the lateral nucleus in the amygdala, and
Purkinje cells in the cerebellum. The pattern of devel-
opmental alterations of the brain structures’ volume
and number of neurons limited to these few brain regions
is consistent with several morphometric and MRI studies,
but is in striking contrast to the abnormal trajectories of
neuronal soma volume growth detected in 14 of 16 exam-
ined brain structures of 4- to 8-year-old children with
autism. The number of regions with a significant deficit of
neuronal soma volume decreases to three in autistic teen-
agers/young adults and has been observed in only four
regions in 36- to 60-year-old autistic individuals [35]. This
disparity between the limited alterations of brain struc-
tures’ volume and number of neurons but the common
neuronal volume deficit in children and an increase of
perikaryon volume in autistic teenagers and adults sug-
gests a separation of mechanisms controlling developmentalchanges of the number of neurons and of brain structure
volume from mechanisms that control brain region–spe-
cific trajectories of neuron growth. These two studies
suggest that some neuronal populations—Purkinje cells,
neurons in the caudate nucleus and accumbens, and in
the lateral nucleus of the amygdala—are affected by both
mechanisms.
Cerebellum
Studies of the cerebellum of individuals diagnosed with
autism provide inconsistent results, including smaller
cerebellar hemispheres [45,46] and smaller vermis [47-49]
as well as increased cerebellar volume or volume propor-
tional to brain size [50]. The study by Fatemi et al. [25] of
the cerebellum of five males with autism with a mean age
of 25.2 years and of five age-matched controls revealed a
24% decrease in mean Purkinje cell size but no differences
in Purkinje cell densities. The study of the cerebellum of a
16-year-old female diagnosed with autism and severe in-
tellectual deficit showed no alterations in the cerebellum
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the size of the vermis and attention deficits, enhanced
stereotypic behavior, and reduced exploration in aut-
ism [51-53].
Our review of the literature indicates that the current
study is the first to report on the total number of Pur-
kinje cells and cerebellar global volumetry in autism.
The study revealed a significantly lower total number of
Purkinje cells in the cerebellum in the group of subjects
who were diagnosed with autism (12.1 million per exam-
ined hemisphere, and 24.2 million calculated for entire
cerebellum) than in control subjects (16.0 and 32.0 mil-
lion, respectively). The total number of Purkinje cells in
the entire cerebellum of control subjects in our cohort
4–64 years of age is comparable to estimates reported by
other authors, with some modifications due to age and
methods: 28.5 million in 10 control males, 28–84 years
of age [54]; 28.6 million in 19 control subjects, 19–84
years of age [55], 29.8 million in 10 controls, 21–65 years
of age [56]; and from 19.7 to 27.0 million in four controls,
41–84 years old [57].
Autism is associated with significant inter-individual
differences in the number of Purkinje cells, but a smaller
number of Purkinje cells was observed in the majority of
29 individuals diagnosed with autism (reviewed by Palmen
et al., [58]). Recently, eight subjects with autism and seven
control subjects from our cohort of 14 autistic and 14
control subjects were examined by Skefos et al. [59] to
detect links between structural alteration of four cerebellar
subdivisions and functional abnormalities typical for aut-
ism. The authors examined the crus I and II in the poster-
ior lobe reciprocally connected with prefrontal cortical
networks that modulate social behavior, and the hemi-
spheric portion of lobules IV-VI known as a primary sen-
sorimotor processing area. The lower Purkinje cell density
in these regions supports the hypothesis that abnormal
Purkinje cell density may contribute to selected clinical
features of the autism phenotype. The reduced number of
Purkinje cells and dysplastic changes in lobule X may have
a direct contribution to alterations of eye movement in
subjects with autism [60]. Some studies suggest that a
regional decrease in the number of Purkinje cells may be
the result of prenatal loss of Purkinje cells [27]. Some
inter-individual differences in the number of Purkinje cells
reported in the past might be related to treatment of
epilepsy-associated loss of Purkinje cells [61-64] and/or
pre-mortem changes related to the mechanism of death.
Signs of structural developmental alterations coincide with
a 40% decrease in the expression of glutamic acid decarb-
oxylase 67 (GAD67) mRNA in autistic subjects and an in-
creased GABAergic feed-forward inhibition to Purkinje
cells by basket cells. These data suggest a disruption in the
timing of Purkinje cell firing and altered inhibition of the
cerebellar nuclei, which could directly affect cerebello-cortical output, leading to changes in motor behavior and
cognition [65].
In the examined cohort, the difference between volumes
of the cerebellar hemisphere in the group with autism and
control groups (31,779 mm3 and 31,133 mm3, respect-
ively) was not significant. This volume reflects a 45%
reduction of brain weight during dehydration in ethyl
alcohol of the brains of control subjects and a 47% re-
duction in individuals diagnosed with autism. The volume
calculated for both cerebellar hemispheres of control
subjects and corrected for 45% shrinkage is equal to
113.2 mm3 and is comparable to 124.8 cm3 in the study
by Andersen et al. [55] of 19 control males from 19 to
84 years of age.
This study found a significant—25%—deficit in the
number of Purkinje cells in the absence of significant
differences between affected and control cohorts in the
volume of the molecular and granule cell layer, cerebel-
lar white matter, or total volume of cerebellar nuclei.
Previous study revealed severe Purkinje cell soma volume
deficits in the range of 31% in 4- to 8-year-olds and of
23% in 29- to 60-year-olds [35]. These findings, and the
absence of abnormalities in the number and distribution
of GABAergic basket and stellate interneurons in the cere-
bellar molecular layer reported by Whitney et al. [27], sug-
gest that Purkinje cells are the major target of the genetic
and/or epigenetic factors that define the contribution of
Purkinje cells’ pathology to the autistic phenotype.
Striatum
In our control cohort the volume of the caudate nucleus
was estimated as 1,727 mm3, versus 2,212 mm3 in
Kreczmanski et al. [66] study, and 2,043 mm3 in Bogerts
study [67] (with Kreczmanski’s et al. correction for shrink-
age). The volume of the putamen was 2,365 mm3 in our
material, 2,713 mm3 in Kreczmanski et al. study [66], and
2,979 mm3 in Bogerts study [67] (with Kreczmanski's
correction for shrinkage). The volume of the nucleus
accumbens was estimated as 182 mm3 in this study,
204 mm3 in Kreczmanski et al.[66], 147 mm3 in Lauer et al.
[68] (with Kreczmanski’s shrinkage factor), and 138 mm3
in Pakkenberg study based on examination of 4-μm thick
paraffin sections [69].
The volume of the caudate nucleus was significantly
greater in the group with autism than in the control group
(2,107 mm3 and 1,727 mm3, respectively; p < 0.036).
Several MRI studies of patients with autism have revea-
led increased volumes of the basal ganglia [20,70-72]
and a correlation between caudate nucleus volumes and
repetitive-behavior scores [70,71]. A direct relationship
between repetitive behaviors and right caudate nucleus
volume was reported in an cohort of 17–55 years of age
patients diagnosed with autism [71], but not in a cohort
including children [73]. Brain size increases to the age
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until late childhood [18,74] and decreases during adult-
hood [73,75]. Regional reduction of the caudate nucleus
head volume by up to 50% and the presence of foci of
tissue loss, detected by repeated scanning with high-
resolution MRI and use of continuum mechanical tensor
maps, were interpreted as evidence of the pruning process
at 9–13 years of age in control subjects [74]. The lack of
differences on postmortem evaluation of caudate nucleus
volume between 4- to 8-year-old autistic and age-matched
control subjects, but the significantly larger caudate nu-
cleus and nucleus accumbens and insignificantly higher
(by 11%) total number of neurons in these structures in
9- to 60-year-old subjects diagnosed with autism in our
cohort may indicate timely pruning in the control group,
but regionally defective pruning in affected subjects, as
postulated by Voelbel et al. [76].
A subcomponent of changes in the striatum is the
significant deficit in the volume of neuronal soma in the
nucleus accumbens (34%) and caudate nucleus (22%) in
4- to 8-year-old subjects with autism, but not in affected
adolescents or adults [35]. These data suggest the de-
regulation of mechanisms that control the number and
volume of neurons and the total volume of the caudate
nucleus and nucleus accumbens. Correlations between
MRI-detected alterations within the striatum and the
severity of clinical changes [70,71] imply that these cellular
alterations may contribute to stereotyped and ritualistic
behaviors in autism. The nucleus accumbens, which is
considered a mixed structure with elements of the stri-
atum and the amygdala [77], processes information about
reward value and availability and is involved in reward-
related behaviors [78]. Projections of nucleus accumbens
neurons to the ventral pallidum translate reward infor-
mation into motivated action [79]. A significantly larger
nucleus accumbens (by 34%, p < 0.050) appears to be an-
other deregulated component of striatal circuits that may
enforce repetitive behaviors in autism.
The striatum alterations observed in idiopathic autism
resemble some structural and functional changes observed
in fragile X syndrome (FXS). Autism is diagnosed in 25–
30% of individuals diagnosed with FXS [80-84]. Hatton
et al. [82] suggested that lower levels of fragile X mental
retardation protein (FMRP) expression contribute to autis-
tic behavior and intellectual deficits in children with FXS.
Gothelf et al. [85] revealed a correlation between lower
levels of FMRP, behavioral alterations, and alterations of the
size of some brain subdivisions, including increased size of
the caudate nucleus but decreased size of the amygdala,
superior temporal gyrus, and posterior cerebellar vermis in
FXS. A 75% reduction of FMRP expression in vermis and
a 50% reduction in the superior frontal cortex (BA9) in
adults with idiopathic autism may contribute to both struc-
tural abnormalities and the autistic phenotype [86].Amygdala
Neuropathological studies [87] and results of structural
[10,88] and functional [89] neuroimaging indicate that the
amygdala is affected in autism. The study by Schumann
and Amaral [31] of the amygdala in nine brains of indi-
viduals with autism 10–44 years of age and 10 brains of
age-matched controls did not reveal a difference in the
number of neurons in the basal, accessory basal, and cen-
tral nucleus. However, the authors reported 13% fewer
neurons in the lateral nucleus (3.47 million in the autistic
group and 4.00 million in the control group; p < 0.05) and
12% fewer neurons in the entire amygdala (10.74 million
in the affected group and 12.21 million in the control
group; p < 0.05). The significantly (p < 0.017) reduced nu-
merical density of neurons in the lateral nucleus in the
amygdala of subjects with autism in our cohort of 14 sub-
jects 4–60 years of age (24,390/mm3 in the affected group
and 27,446/mm3 in the control group) and the absence of
significant changes in other amygdala subdivisions in these
subjects confirm the selective developmental abnormality
of the lateral nucleus. In our study, the total number of
neurons in the lateral nucleus in subjects with autism was
also less (by 17%) (4,609,751) than in the control group
(5,544,098), but after control for five covariates, the differ-
ence was found to be not significant. Differences in tissue
preservation, the age of examined subjects, and selection
of only epilepsy-free males in the study by Schumann and
Amaral [31] may contribute to some differences in the
number of neurons reported, but the general pattern of
alterations detected in both studies is similar.
Reduced neuronal density in the absence of a change
in the total number of neurons in the amygdala may
suggest the involvement of non-neuronal factors, includ-
ing glia. Ahlsen et al. [90] reported increased levels of
GFAP, a marker of astroglial activation, in the CSF in sub-
jects with autism. There are no data about astrocytosis
within the amygdala, but Laurence and Fatemi [91] dem-
onstrated by Western blots an increased level of GFAP in
superior frontal cortex (BA9; by 45%), parietal cortex
(BA40; by 75%) and in the cerebellum (by 49%) in subjects
with autism. Vargas et al. [92] reported signs of selective
activation of astroglia and microglia in several brain re-
gions of subjects with autism. A new concept of tripartite
synapses with astrocytes controlling synapses formation
and function [93] and signs of astrocytosis may suggest a
glial contribution to structural and functional changes in
the brains of subjects diagnosed with autism.
Individuals with autism display deficits of social behavior,
including abnormalities in social reciprocity, difficulties in
the use of eye contact, and deficits in social motivation [1].
The theory of mind proposes that the amygdala is one
of several brain regions that are parts of the social brain
and are necessarily abnormal in autism [89]. Moreover,
the amygdala controls behavioral responses such as the
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ism [94,95]. The alterations in the amygdala detected in
morphometric studies and in MRI-based volumetry sug-
gest that developmental abnormalities of the amygdala
may contribute to the autistic phenotype. Some differences
of the estimated total number of neurons in the lateral
nucleus in the amygdala in the control group in Schumann
and Amaral [4] study (4.0 million), Kreczmanski et al.
[66] (4.43 million) and 5.54 million in our study reflect
mainly technical differences and in part interindividual
differences.
Neocortex and archicortex
Stoner et al. study [96] revealed patches of disorganization
in the prefrontal and temporal cortices in a majority of
children diagnosed with autism. This focal disruption of
cortical architecture suggests dysregulation of layer forma-
tion and layer-specific neuronal differentiation at prenatal
developmental stages. Van Kooten et al. [32] showed sig-
nificant reductions in neuron densities in layer III, total
number of neurons in layers III, V, and VI in the fusiform
gyrus, but none of these alterations were found in the
primary visual cortex or the whole cerebral cortex. This
study provides insight about the cellular basis of abnor-
malities in face perception in autism. Several other reports
indicated the absence of alterations in the number of neu-
rons in the cerebral cortex [97]; in the superior frontal
cortex [98]; in the BA44 and BA45 [28]; and in the fron-
toinsular cortex [23]. A study of von Economo neurons
revealed no significant difference in the mean number of
these neurons in the frontoinsular cortex [26] and in the
anterior cingulate cortex (BA24) [33]. A study of the fron-
toinsular cortex in four subjects with autism, (4–11 years
of age) and three control (4–14 years of age) subjects
revealed an increase in the ratio between von Economo
neurons and pyramidal neurons, but the difference be-
tween the number of von Economo neurons in subjects
with autism and control subjects fell short of statistical
significance, and the total estimated number of pyramidal
neurons did not reveal a significant difference [23].
Our study of the archicortex of subjects with autism
revealed focal microdysgenesis with selective deficits of
stellate neurons in irregular smaller islands in the second
layer of the entorhinal cortex in 23- and 60-year-old af-
fected subjects [36]. The reduced total number of neurons
in the islands and in the third layer of the entorhinal cortex
suggests developmental abnormalities within the perforant
pathway projecting to the dentate gyrus and Ammons
horn. These alterations may affect memorization and emo-
tional behavior [99]. Similar deficits of stellate neurons in
islands and a thicker molecular layer in the entorhinal
cortex of subjects diagnosed with schizophrenia were de-
scribed as evidence of defects of migration of neurons to
their target destination during development [100,101].Developmental deficit and loss of neurons in autism
For much of the history of postmortem studies of ASD
pathology, brain abnormalities have been viewed as static
[102], but the regression observed in 15–62% of autism
cases has been linked to neurodegeneration and neuronal
loss [103]. However, morphological markers of neurode-
generation have been reported only sporadically, including
cytoplasmic homogenous inclusions in Purkinje cells
in affected child [98], Purkinje and granule cells’ mine-
ralization [87], and neurofibrillary degeneration in a
24-year-old autistic female with self-injurious behavior
including head-banging [104].
The Fatemi et al. [105] review demonstrates agreement
on a Purkinje cells deficit in the cerebellum of individuals
diagnosed with autism. The lower number of Purkinje
cells in subjects diagnosed with autism is considered
mainly the result of the loss of these cells before 30 weeks’
gestation [87], but postnatal Purkinje cell death accom-
panied by astrocytosis has been also reported [98]. In
some cases, loss of Purkinje cells might be the result of
chronic treatment with anti-epileptogenic drugs such as
phenytoin [61,62]. The lack of correlation between the
number of Purkinje cells and age in the examined cohort
of autistic subjects 4–60 years of age suggests that the
25% deficit of Purkinje cells is mainly a developmental
fetal defect, as postulated by Kemper and Bauman [87],
but the combination of prenatal deficit and postnatal loss
cannot be excluded.
Comparison of the total number of neurons in the
Ammons horn in this control group and control groups
in other reports reveals differences related to the methods
of tissue preservation and morphometric evaluation, and
the age of examined cohorts. Our study revealed that the
total numbers of neurons in the CA1, CA2/3, and CA4
sectors of control subjects 4–64 years of age were 11.5,
2.1, and 1.1 million, respectively. The numbers of neurons
in the CA1, CA2/3, and CA4 sectors in control subjects
21–56 years of age were determined to be 14.7, 2.7, and
2.12 million, respectively [106]; for 47– 85 years of age,
16.0, 2.7, and 2.0 million, respectively [107]; and for 72–96
years of age, 6.2, 1.7, and 0.7 million, respectively [108].
Similar, age-associated differences are observed in the
substantia nigra, with the total number of neurons of
707,000 in our control group, and of 550,000 neurons
in 71- to 87-year-old control subjects in the Pakkenberg
et al. study [109].
Several studies have revealed neuronal pathology af-
fecting cytoplasmic organelles and possibly sustaining
functional abnormalities in autism, but there is no direct
evidence that they cause significant neuronal death. An
abnormal electron transfer chain in neuronal mitochon-
dria may alter energy generation, metabolism, and cell
structure and function; however, these changes prevail
only in children, not in adults [110,111]. An imbalance
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creases the mass of compromised mitochondria in neu-
rons in the temporal cortex, but this pathology was also
demonstrated only in young individuals diagnosed with
ASD [112]. Currently, there is no evidence that the
elevated oxidative stress detected as an increase of
3-nitrotyrosine in the cortex, cerebellum, and pons
of subjects with autism [113] and the two-fold increase of
DNA oxidation in the frontal and temporal cortex
and in the cerebellum [114] cause neuronal loss. In
idiopathic autism and autism associated with dup15, a
self-enhancing cascade of pathological changes alters
amyloid precursor protein (APP) metabolism, and in-
creases cytoplasmic accumulation of amino-terminally
truncated amyloid-β, which is the source of reactive oxy-
gen species and which increases the formation of lipid
peroxidation products. These changes enhance amyloid-β
deposition and sustain the cascade of changes contribut-
ing to metabolic and functional impairments in neurons
[115,116]. These alterations may contribute to activation
of astrocytes and microglial cells, enhanced astrocytosis,
and astrocytes’ death [115]; however, the potential neur-
onal loss associated with this pathology appears to be
hidden within a range of interindividual differences and
was not detected as an age-associated correlate in the
examined cohort.
Conclusions
The alterations in regional volume and neuron number
in only a few brain structures in the autism cohort we
studied here contrast with the brain region–specific
developmental deficits in the volumes of neuronal soma
detected in almost all examined brain regions as shown
in our previous report [35]. This disparity may reflect
a separation of mechanisms controlling developmental
changes in neuronal number and brain structures’ volume
from mechanisms controlling brain region–specific trajec-
tories of neuronal growth. However, the severe deficit of
Purkinje cell, and significant alterations of the volume of
striatum and amygdala subdivisions and their neuronal
number, combined with prominent alterations of tra-
jectories of neuronal growth, suggest that developmental
abnormalities of these brain structures are products of
mechanisms controlling both structures’ size and neuronal
number and volume. This duplication of mechanisms
controlling the different types of developmental abnormal-
ities in a few brain regions may amplify their contribution
to the repetitive behaviors and social and communication
deficits observed in autism.
This study increases the coherence of comparative
stereological characteristics by the assessment of 38 brain
structures and cytoarchitectonic subdivisions in a relatively
large cohort of subjects diagnosed with autism using one
standard of tissue preservation, embedding, sectioning, andstaining and unbiased stereological estimates. The con-
sistency of the characteristics of this cohort is enhanced
by our previous analysis of qualitative developmental ab-
normalities [36], the study of trajectories of neuronal soma
changes throughout the lifespan [35], and the applica-
tion of a major portion of this material for unbiased
stereological studies of developmental abnormalities
in the cerebral cortex [23,28,32], cerebellum [59], and
brainstem [34].Consent
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